Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Eucalyptus Globulus
Brand Name
Dermveda Complete Lice Treatment Natural Serum
Generic Name
Eucalyptus Globulus
Active Ingredient
Eucalyptus Globulus LeafCategory
Standardized Insect Venom Allergenic Extract [EPC]
Variants
1
Different strengths and dosage forms
| Strength | Form | Route | NDC |
|---|---|---|---|
| 6 [hp_X]/118mL | LIQUID | TOPICAL | 83819-030 |
Detailed information about Dermveda Complete Lice Treatment Natural Serum
This page is for informational purposes only and does not replace medical advice. Before using any prescription or over-the-counter medication for Dermveda Complete Lice Treatment Natural Serum, you must consult a qualified healthcare professional.
Eucalyptus Globulus Leaf is utilized in medical practice primarily as a Non-Standardized Plant Allergenic Extract and is classified under various EPCs including Nitrogen Binding Agents and Adrenergic Agonists for diagnostic and therapeutic applications.
The dosage of Eucalyptus Globulus Leaf products varies significantly based on the route of administration and the condition being treated.
Eucalyptus Globulus Leaf must be used with extreme caution in pediatric populations.
Since the metabolites of Eucalyptus Globulus Leaf are primarily excreted by the kidneys, patients with a GFR (Glomerular Filtration Rate) below 30 mL/min should use these products with caution. While specific dose reduction protocols are not standardized, increased monitoring for systemic toxicity is recommended.
Patients with significant liver cirrhosis or acute hepatitis may experience reduced metabolism of 1,8-cineole. Healthcare providers may suggest a 50% dose reduction or longer intervals between doses to prevent accumulation.
Geriatric patients often have thinner skin (increasing topical absorption) and reduced renal clearance. Providers typically start at the lowest end of the dosing spectrum and monitor for CNS side effects, such as dizziness or confusion.
If you miss a dose of an oral or topical eucalyptus product, take it as soon as you remember. However, if it is nearly time for your next dose, skip the missed one. Do not double the dose. For missed immunotherapy injections, contact your allergist immediately; missing multiple doses may require 'stepping back' to a lower concentration to ensure safety.
Eucalyptus poisoning can be life-threatening, especially in children. Signs of overdose include:
In case of suspected overdose, contact a Poison Control Center or seek emergency medical care immediately. Gastric lavage and activated charcoal may be required if the ingestion occurred within the last hour.
> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose without medical guidance.
When used as directed, Eucalyptus Globulus Leaf is generally well-tolerated, but certain reactions occur frequently:
> Warning: Stop taking Eucalyptus Globulus Leaf and call your doctor immediately if you experience any of these.
Prolonged use of Eucalyptus Globulus Leaf products can lead to:
While Eucalyptus Globulus Leaf as a botanical does not always carry a standard FDA Black Box Warning, Allergenic Extracts as a class carry a significant warning regarding Anaphylaxis Risk. The warning states that these products can cause severe, life-threatening systemic reactions. They must only be administered by physicians trained in the treatment of anaphylaxis and in facilities equipped to handle such emergencies. Patients must be observed for at least 30 minutes following administration.
Report any unusual symptoms to your healthcare provider.
Eucalyptus Globulus Leaf is a potent pharmacological agent that requires careful handling. It is not 'just a natural remedy'; its components can interact with vital organ systems and affect the metabolism of other medications. Patients must ensure they are using the correct form (e.g., never ingesting essential oils meant for inhalation) to avoid severe toxicity.
Eucalyptus Globulus Leaf extracts used for immunotherapy are associated with a risk of anaphylaxis. Healthcare providers must ensure patients are stable before administration. Patients with unstable asthma are at a significantly higher risk for fatal reactions and should generally not receive allergen immunotherapy.
For patients on long-term therapy or immunotherapy, the following may be required:
Eucalyptus Globulus Leaf generally does not cause drowsiness. However, if a patient experiences dizziness or CNS excitation as a side effect, they should refrain from driving or operating heavy machinery until the symptoms resolve.
Alcohol may increase the sedative effects of some eucalyptus metabolites and can increase the risk of gastrointestinal irritation. It is advisable to limit alcohol consumption while taking oral eucalyptus supplements.
There is no known withdrawal syndrome associated with Eucalyptus Globulus Leaf. However, for immunotherapy, stopping the treatment abruptly will result in a loss of the desensitization effect, and the patient's allergy symptoms will likely return to baseline levels.
> Important: Discuss all your medical conditions with your healthcare provider before starting Eucalyptus Globulus Leaf.
For each major interaction, the mechanism typically involves CYP450 enzyme induction or inhibition or pharmacodynamic synergy (where two drugs have similar effects on the body). Management usually involves dose timing adjustments or increased clinical monitoring.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking.
Eucalyptus Globulus Leaf must NEVER be used in the following circumstances:
Conditions requiring a careful risk-benefit analysis include:
Patients allergic to other members of the Myrtaceae family—including tea tree (Melaleuca), clove, allspice, and guava—may exhibit cross-reactivity to Eucalyptus Globulus Leaf. If you have a known allergy to any of these substances, inform your allergist before undergoing testing or treatment with eucalyptus extracts.
> Important: Your healthcare provider will evaluate your complete medical history before prescribing Eucalyptus Globulus Leaf.
Eucalyptus Globulus Leaf is generally categorized as FDA Pregnancy Category C (or equivalent). This means that animal reproduction studies have not been conducted, and there are no adequate and well-controlled studies in humans. It is unknown whether the components can cause fetal harm or affect reproduction capacity. Use during pregnancy should only occur if the potential benefit clearly outweighs the potential risk to the fetus. Avoid high-dose oral or extensive topical use during the first trimester.
Components of Eucalyptus Globulus Leaf, particularly 1,8-cineole, are known to be excreted into breast milk. While small amounts may be harmless, the characteristic odor can cause 'nursing strike' (infant refusal to breastfeed) or mild sedation in the infant. There is also a theoretical risk of skin irritation if applied topically to the breast area. Nursing mothers should consult their pediatrician before using systemic eucalyptus products.
As previously noted, the use of eucalyptus in children is highly restricted. It is NOT approved for use in children under 2 years of age. For older children, it should be used at the lowest effective dose for the shortest duration possible. Growth effects have not been formally studied, but long-term systemic use is generally avoided in pediatric populations unless part of a supervised immunotherapy program.
Clinical studies have not identified specific differences in response between the elderly and younger patients. However, the risk of polypharmacy interactions is significantly higher in this group. Geriatric patients are also more susceptible to the CNS side effects of terpenes. Providers should monitor renal function (creatinine clearance) as a guide for dosing systemic eucalyptus products in patients over 65.
In patients with chronic kidney disease (CKD), the clearance of glucuronide metabolites is delayed. While not strictly contraindicated, patients with Stage 4 or 5 CKD should avoid high-dose oral therapy. Dialysis is not expected to significantly clear eucalyptus components due to their high protein binding.
For patients with Child-Pugh Class B or C hepatic impairment, the half-life of eucalyptus components may be doubled or tripled. Dose reductions of 50-75% are often necessary to prevent systemic accumulation and potential neurotoxicity.
> Important: Special populations require individualized medical assessment.
Eucalyptus Globulus Leaf acts primarily through its major constituent, 1,8-cineole. This molecule functions as a potent anti-inflammatory and bronchodilating agent. It inhibits the production of pro-inflammatory mediators, such as Leukotriene B4 and Interleukin-1β, in human monocytes. Additionally, it acts as an Adrenergic alpha and beta agonist, stimulating receptors that control vascular tone and airway diameter. In its role as a Nitrogen Binding Agent, it participates in the molecular sequestration of ammonia-related compounds, though the clinical significance of this in standard respiratory therapy is secondary to its secretolytic effects.
The onset of action for inhaled eucalyptus is rapid, occurring within 5 to 15 minutes. For oral cineole, the maximum effect on the respiratory mucosa is typically seen within 2 hours. The duration of effect is generally 4 to 6 hours. Tolerance to the bronchodilatory effects is rare, but the immune-modulating effects in immunotherapy require months or years of consistent exposure to reach peak efficacy.
| Parameter | Value |
|---|---|
| Bioavailability | 60-70% (Oral) |
| Protein Binding | 85% |
| Half-life | 1.5 - 4 hours |
| Tmax | 1 - 2 hours |
| Metabolism | Hepatic (CYP2B6, CYP3A4) |
| Excretion | Renal 80%, Pulmonary 20% |
Eucalyptus Globulus Leaf is classified as a Non-Standardized Plant Allergenic Extract. It shares therapeutic space with other botanical extracts like Ambrosia artemisiifolia (Ragweed) and Phleum pratense (Timothy Grass) in the field of allergy, and with medications like guaifenesin in the field of respiratory medicine.
Common questions about Dermveda Complete Lice Treatment Natural Serum
Eucalyptus Globulus Leaf is primarily used in two ways: as a diagnostic and therapeutic tool for allergies and as a treatment for respiratory symptoms. In allergy medicine, it is used in skin tests to identify eucalyptus hypersensitivity and in 'allergy shots' to help desensitize the immune system over time. For respiratory health, it acts as an expectorant to help clear mucus and as a bronchodilator to open airways during conditions like bronchitis or the common cold. Some topical forms are also used to relieve minor muscle and joint pain. Always consult your doctor to see which form of eucalyptus is appropriate for your specific health needs.
The most common side effects depend on how the medication is used. For those receiving allergy injections, redness, itching, and swelling at the injection site are very common. When taken orally, many people notice a eucalyptus scent on their breath or experience mild stomach upset and nausea. Topically, it may cause a temporary cooling or tingling sensation on the skin, which can sometimes turn into mild redness or irritation. Most of these effects are temporary and disappear once the body adjusts to the medication or the treatment is stopped.
It is generally recommended to limit or avoid alcohol while taking systemic forms of Eucalyptus Globulus Leaf. Alcohol can increase the risk of gastrointestinal irritation and may enhance the mild sedative effects that some people experience with high doses of eucalyptus. Furthermore, alcohol can interfere with the body's ability to respond to emergency medications like epinephrine if you were to have a severe allergic reaction to the extract. Always discuss your alcohol consumption habits with your healthcare provider before starting a new medication.
The safety of Eucalyptus Globulus Leaf during pregnancy has not been fully established through clinical trials. It is currently categorized as a drug that should only be used if the potential benefits to the mother outweigh the potential risks to the developing baby. While topical use on small areas is generally considered low-risk, oral supplements or intensive inhalation therapy should be approached with caution, especially in the first trimester. Pregnant women should always consult their obstetrician before using any botanical or allergenic extract.
The time it takes for Eucalyptus Globulus Leaf to work depends on the symptom being treated. For nasal congestion or cough, inhalation of eucalyptus vapors can provide relief within 5 to 15 minutes. Oral capsules for bronchitis typically take 1 to 2 hours to reach peak effectiveness in the bloodstream. However, if you are using eucalyptus for allergen immunotherapy (allergy shots), it may take several months of regular treatment before you notice a significant reduction in your allergy symptoms. Consistency is key for long-term immunological benefits.
For most uses, such as treating a temporary cold or cough, you can stop taking Eucalyptus Globulus Leaf suddenly without any withdrawal symptoms. However, if you are undergoing allergen immunotherapy, stopping the treatment abruptly can interfere with the desensitization process. If you stop your allergy shots for an extended period, your doctor may need to restart you at a lower dose to ensure safety when you resume. Always talk to your allergist before deciding to discontinue a long-term immunotherapy schedule.
If you miss an oral dose or a topical application, take it as soon as you remember, unless it is almost time for your next scheduled dose. In that case, simply skip the missed dose and continue with your regular schedule; never double your dose to make up for a missed one. If you miss an appointment for a eucalyptus allergy injection, call your doctor's office immediately. They will provide specific instructions on when to come in and whether your dose needs to be adjusted based on how much time has passed since your last shot.
There is currently no clinical evidence to suggest that Eucalyptus Globulus Leaf causes weight gain. The medication does not affect metabolic rate or appetite in a way that would lead to increased body fat. If you notice sudden weight gain or swelling while taking this or any other medication, it is important to contact your healthcare provider, as this could be a sign of an unrelated medical condition or a rare side effect involving fluid retention. Maintaining a balanced diet and regular exercise remains the best way to manage weight while on this treatment.
Eucalyptus Globulus Leaf can interact with several types of medications, so caution is necessary. It is particularly important to tell your doctor if you are taking beta-blockers, diabetes medications, or drugs that are processed by the liver's CYP3A4 enzyme. Eucalyptus may also interact with other herbs or supplements that affect blood sugar or liver function. To ensure your safety, provide your healthcare provider with a complete list of all prescription drugs, over-the-counter medicines, and herbal supplements you are currently using before starting eucalyptus therapy.
Eucalyptus Globulus Leaf is a botanical substance, and while it is not 'generic' in the same way a synthetic drug like ibuprofen is, it is available from many different manufacturers under various brand names and as non-branded extracts. In the world of allergy medicine, different laboratories produce eucalyptus extracts that are considered therapeutically equivalent, though they may not be identical. Most insurance plans cover these extracts as part of standard allergy testing and treatment. Always check the label to ensure you are getting a high-quality, pharmaceutical-grade product.
Other drugs with the same active ingredient (Eucalyptus Globulus Leaf)